PrimeMuPharma Overview
- Year Founded
-
2023
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
PrimeMuPharma General Information
Description
Developer of a biotechnology platform designed for treatments for aging-related diseases. The company provides drug candidates targeting mitochondrial function and cellular processes associated with aging, focusing on conditions such as hearing loss, macular degeneration, and muscle wasting, enabling the healthcare market to investigate therapeutic approaches for age-related diseases and support healthy aging.
Contact Information
Website
www.primemupharma.comCorporate Office
- 5Floor, Building 1, 807 Hoguk-ro, Buk-gu
- Hakjeong-dong, Chilgok Kyungpook National University Hospital
- Daegu, 41404
- South Korea
Corporate Office
- 5Floor, Building 1, 807 Hoguk-ro, Buk-gu
- Hakjeong-dong, Chilgok Kyungpook National University Hospital
- Daegu, 41404
- South Korea
PrimeMuPharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Out of Business | 20-Sep-2026 | Completed | Out of Business | |||
| 2. Accelerator/Incubator | 01-Jul-2023 | Completed | Startup | |||
| 1. Accelerator/Incubator | 01-Jan-2023 | Completed | Startup |
PrimeMuPharma FAQs
-
When was PrimeMuPharma founded?
PrimeMuPharma was founded in 2023.
-
Where is PrimeMuPharma headquartered?
PrimeMuPharma is headquartered in Daegu, South Korea.
-
What industry is PrimeMuPharma in?
PrimeMuPharma’s primary industry is Drug Discovery.
-
Is PrimeMuPharma a private or public company?
PrimeMuPharma is a Private company.
-
What is PrimeMuPharma’s current revenue?
The current revenue for PrimeMuPharma is .
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process